California Redbud (Cercis occidentalis): A Comprehensive Reference
1. Identity and Botanical Description
Nomenclature and Taxonomy
California redbud (Cercis occidentalis) is a small tree or shrub in the legume family, Fabaceae. It is also commonly known as western redbud. Botanically, redbuds belong in the legume family, within the subfamily Caesalpinioideae. The taxonomy of the species has undergone revision: the scientific name of California redbud is alternatively listed as Cercis orbiculata Greene (Fabaceae), with common names including California redbud, western redbud, Arizona redbud, and Judas tree. Until recently, plants growing in California were recognized as Cercis occidentalis (western redbud), but this view is now being abandoned among legume taxonomists. Accordingly, current treatments may list the plant under either binomial, and both names appear widely in botanical and ethnobotanical literature.
The genus name Cercis is derived from the Greek kerkis, meaning "weaver's shuttle," a reference to the elongated, flat shape of the seed pods. Redbuds belong in the legume family, within the subfamily Caesalpinioideae, and are relatives of the Mediterranean Judas tree.
Morphology
California redbud is a deciduous shrub to small tree, growing up to 7 metres (23 ft) tall. Its crown is rounded on clustered, erect branches to a width of 10–20 feet (3.0–6.1 m). The branches are thin, shiny, and brown; twigs are slender, erect, and hairless. The leaves are arranged alternately along the twigs and are simple, round, and slightly leathery, growing to 5–9 centimetres (2.0–3.5 in) in diameter, with 12–25-millimetre (0.47–0.98 in) petioles. Flowers bloom in spring from February to April. The shrub bears 3-inch-long brown legume pods which are very thin and dry.
Geographic Distribution
The California or western redbud, C. occidentalis, distinguished from the eastern redbud by its larger flowers and fruits, occurs naturally from the Siskiyou Mountains of northern California southward through the Coast Ranges and the Sierra Nevada to San Diego County, California, eastward to southern Nevada, southwestern Utah, and northwestern Arizona (particularly along the canyons of the Colorado River). In the northern, rainier part of its range, it grows more often on dry slopes in mountain foothills. In the southern and drier part of its range, it grows most often near higher-elevation creeks, canyon bottoms, and other moister areas.
As is the case with other legumes, it is a nitrogen-fixing plant because of the presence of root nodules, allowing symbiotic bacteria to produce nitrogen.
Relationship to Other Cercis Species
California redbud is one of approximately 10 species in the genus Cercis worldwide. Its close relatives include the eastern redbud (Cercis canadensis) and the Chinese redbud (Cercis chinensis). Because C. occidentalis and C. canadensis are so closely related and share overlapping ethnobotanical and phytochemical profiles, much of the pharmacobotanical and ethnomedicinal literature addresses the genus collectively or focuses on C. canadensis or C. chinensis as better-studied proxies. Where specific evidence relates to the closely allied eastern redbud or to genus-level data, this is noted explicitly in the sections below.
Common Forms and Preparations
California redbud is encountered as a dietary supplement or wild food in several forms:
- Fresh or dried flowers — consumed raw, cooked, pickled, or as tea infusions. Developing before the leaves in spring, the flowers are eaten as is or mixed with other foods as an accent.
- Bark and inner bark decoctions or infusions — prepared as tea or fluid extracts, primarily for medicinal use.
- Root bark infusions — cold-steeped or boiled for traditional remedies.
- Young seed pods and seeds — eaten as a food source. The Navajo roasted the seedpods of California redbud in ashes and ate the seeds.
- Young leaves — consumed raw or cooked. Native Americans enjoyed redbud flowers, young seed pods, and even young leaves, both raw and cooked.
- Twig bark — used in basketry and occasionally as a dye source. The straight, pliable, burgundy-colored young shoots of the California redbud were prized by native basket weavers. Designs were woven into baskets with redbud shoots, and a faint reddish dye derived from the bark was used to tint finished baskets.
2. Traditional and Historical Use
Indigenous Californian Peoples
California redbud is important to the ethnobotany of multiple native groups, being used in basketry, and has different names in their respective languages. Botanist Victor King Chestnut recorded the name for the tree in various north California indigenous languages; according to him, the Yuki call the tree Chā'ā, the Koncow call it dop or tal'k, and the Ukiah (cited as Yokia) call it Kälā' ä kälã'. Different Native American tribes have unique names for the western redbud in their languages, such as Chā'ā by the Yuki and Mūlā' by the Northern Pomo.
California redbud is particularly important for the western Mono, foothill Yokuts, and Miwok Native Americans of the central and southern Sierra Nevada of California. Young California redbud shoots, owing to their brilliant red color and straight, flexible structure, are used for basketry. While not identified by name, other Native American nations also used California redbud shoots in basketry.
California tribes used controlled burning specifically to manage the plant's growth for craft purposes. Prior to European settlement, the western Mono, foothill Yokuts, and Miwok Native Americans of the central and southern Sierra Nevada foothills set autumn fires at intervals of 1 to several years to induce rapid elongation of young growth of California redbud. To simulate the burning, the southern Miwok of California manage the plant by coppicing (cutting the plant to within several inches of its base) and selective pruning. California redbud responds to coppicing/pruning as it does to fire, by growing new shoots that are long, straight, and slender, making them ideal for basket-making. Coppicing/pruning generally occurs 1 full growing season prior to harvest.
Medicinal Use by Indigenous Peoples of the American Southwest
In the American Southwest, Native Americans used California redbud roots and bark as a remedy for diarrhea and dysentery. This use parallels the well-documented medicinal application of the closely related eastern redbud by tribes across a wider geographic range. Native Americans, including the Cherokee, Alabama, Navajo, Kiowa, Delaware, and Oklahoma peoples, used eastern redbud (C. canadensis) for culinary, spiritual, and medicinal purposes. One of the common medicinal preparations was an infusion of the bark. They used this infusion to treat flu, whooping cough, vomiting, diarrhea, dysentery, colds, and fever. They also used infusions of the inner bark or roots to relieve congestion.
Regarding the related eastern species, a tea made from the inner bark is highly astringent. A cold infusion of the roots and inner bark has been used to treat various chest complaints including whooping cough and congestion.
Food Use
The flowers can be eaten fresh or fried. In some parts of southern Appalachia, green twigs from the eastern redbud are used as seasoning for wild game such as venison and opossum. Native Americans consume redbud flowers raw or boiled, and eat roasted seeds. The unopened flower buds have historically been pickled as a caper substitute; while just budding, settlers sometimes gathered and pickled them as a local replacement for capers.
Eclectic and 19th-Century Medical Use
In 19th-century American Eclectic medicine, redbud bark was actively employed. Historical practitioners noted that it "can be given when the stomach is irritable, without increasing the trouble, making it very valuable in the treatment of the diarrhoeas peculiar to infancy. But it is in the treatment of chronic diarrhoea and dysentery that its curative action is most manifest." The inner bark of the root was described as the most characteristic drug part, and was reported to be "intensely astringent, exceeding in this respect such well known bodies as the oak and hemlock." In the 19th century it was used to treat diarrhea, dysentery, and various ailments of the reproductive organs and mucous membranes. In the 20th century it has been recommended for use as an astringent and to treat stomach irritation and diarrhea. A treatment for dysentery is made by extracting an astringent extract from the bark.
Wood Use
The wood of western redbud was historically used by Native Americans for making bows. The hard, beautifully grained wood of some Cercis species has been used by cabinet makers for centuries to make veneers and inlays.
3. Key Constituents and Active Compounds
Overview of Genus-Level Phytochemistry
The phytochemistry of California redbud (C. occidentalis) has not been studied in isolation to the same degree as its relatives, but its close phylogenetic position within the genus Cercis means that genus-level data is scientifically relevant. Based on a thorough analysis of the literature, more than 100 compounds have been identified from Cercis species, including flavonoids, phenols, terpenoids, lignins, dibenz[b,f]oxepins, and others. The genus Cercis is a source of interesting specialized metabolites including 82 phenolic compounds comprising 51 flavonoids, ten terpenoids, three cyanogenic glycosides, 54 volatile compounds, and some compounds from other compound classes.
Flavonoids
Flavonoids in Cercis plants include flavonols, flavonoids, isoflavones, flavan-3-ols, dihydroflavonoids, dihydroflavonols, chalcones, and flavone dimers. Research on C. chinensis — the most thoroughly characterized species — has identified specific compounds including myricetrin, quercitrin, afzelin, kaempferol-3-O-α-rhamnopyranoside, and fisetin. Shi et al. determined the contents of myricetrin, quercitrin, and afzelin in Cercis chinensis leaves by HPLC analysis. For C. canadensis specifically, quercetin and catechins have been reported in its leaf tissues.
Phenylpropanoids and Lignans
Literature review across the genus revealed 78 characteristic chemical components in C. chinensis alone, including 32 flavonoids, 11 phenylpropanoids, four lignans, nine stilbenes, 10 polyketide derivatives, and 13 other components. Phenylpropanoid and lignan constituents contribute to the plant's antioxidant and anti-inflammatory profile at the genus level.
Stilbenes
Stilbenes stand out as a class of phenolic metabolites commonly found in Cercis species. Among them, stilbenes are characterized by the presence of two aromatic rings linked by an ethylene bridge, with resveratrol noted as a representative example of this class. In 2007, structurally novel benzo[b,f]oxepin derivatives were discovered in the aboveground part of C. chinensis, which form a dibenz[b,f]oxepin parent nucleus structure by introducing an oxygen bridge ring adjacent to stilbene.
Tannins
The bark and inner bark of Cercis species contain high concentrations of tannins, which are responsible for the pronounced astringent properties noted historically. Early chemical analysis established that redbud contains tannin as the constituent of most marked characteristic, giving it its astringency. This tannin was extracted by alcohol and water, and freely by glycerine. The bark has a high concentration of tannins.
Saponins
The plant is reported to contain a toxic saponin. Saponins are a secondary metabolite class present in many Fabaceae members.
Anthocyanins and Pigments
The vivid pink-to-magenta flower color is attributed to anthocyanin pigments. Anthocyanin extraction and structural characterization have been reported for the closely related C. chinensis, where cyanidin-type anthocyanins have been documented.
Nutritional Constituents of the Flowers and Seeds
The flowers are rich in vitamin C and make a pleasant addition to salads. On a zero moisture basis, the seed contains 22.9–27.5% protein, 7.7–8.8% fat, and 3% ash — though whether the seeds are routinely consumed as a food is not fully established in the botanical literature.
Terpenoids and Other Compounds
Terpenoids have been isolated from multiple Cercis species, primarily from leaf and aerial part fractions. Phenolic acids, cyanogenic glycosides, and polysaccharides have also been reported from various parts of the genus.
4. Established Mechanisms of Action (Genus-Level)
Most mechanistic work on Cercis has been conducted on C. chinensis or C. canadensis in laboratory settings. Phytochemical studies of the Cercis genus have found the isolation of stilbenes, flavonoids, lignans, phenolic acids, cyanogenic glycosides, and others, while pharmacological investigations have revealed anti-inflammatory, antioxidant, antithrombotic, bacteriostatic, anticoagulant, and hypoglycemic activities.
- Astringency and antidiarrheal action: The high tannin content of the bark protein-precipitates mucous membranes, reducing fluid secretion and providing the astringent action historically relied upon for diarrhea and dysentery treatment.
- Antioxidant activity: Isolated compounds from C. glabra leaves were assessed for antioxidant activities through ABTS, DPPH, and PTIO methodologies. Several compounds exhibited evident antioxidant activities.
- Alpha-glucosidase inhibition: Ethyl acetate and n-butanol fractions from C. chinensis flowers exhibited antioxidant and alpha-glucosidase inhibitory activity in vitro. Eight compounds were isolated and identified, including ethyl gallate, kaempferol-3-O-α-rhamnopyranoside, fisetin, and vanillic acid, among others. Ethyl gallate showed the highest antioxidant activity by scavenging DPPH radical and reducing ferric ion.
- Tyrosinase and acetylcholinesterase inhibition: All isolated compounds were evaluated for inhibitory activities against mushroom tyrosinase and acetylcholinesterase. Multiple compounds exhibited evident antioxidant activities.
- Anti-inflammatory activity: The flavonoids and stilbenes found across Cercis species are known to modulate inflammatory pathways at the cellular level; these effects have been documented in preclinical studies of related species.
5. Scientific Evidence by Area of Use
Important note on evidence quality: There is, as of the latest available literature, no published human clinical trial or randomized controlled trial evaluating California redbud (C. occidentalis) as a dietary supplement or therapeutic agent. As a traditional plant with both ornamental and medicinal value, the pharmacological activity of Cercis species is increasingly receiving attention from the academic community. Although modern research has confirmed rich bioactive components, there is currently a lack of systematic chemical and pharmacological reviews. The scientific evidence base is therefore confined to in vitro (cell-based) and, to a limited degree, animal studies conducted primarily on the closely related C. chinensis and C. canadensis.
5.1 Antioxidant Activity
Evidence type: In vitro, preclinical only. No human studies exist.
Multiple studies on the genus have demonstrated free-radical-scavenging activity in laboratory assays. Extracts and chemical constituents derived from Cercis species exhibited significant antioxidant, analgesic, anti-inflammatory, antitumor, and antibacterial activities in preclinical investigations. Specifically for flowers, the ethanol extract of C. chinensis leaf showed remarkable anti-inflammatory and analgesic effects, and ethyl acetate and n-butanol fractions exhibited antioxidant and alpha-glucosidase inhibitory activity in vitro. These findings are preliminary and their relevance to human health remains unestablished.
5.2 Antidiarrheal / Gastrointestinal Activity
Evidence type: Traditional use and historical eclectic medical documentation. No controlled clinical trials.
An astringent fluid extract from redbud bark has been used historically in treating dysentery. The mechanism — precipitation of intestinal proteins via tannins — is pharmacologically plausible, but has not been tested in human clinical trials for either C. occidentalis or any closely related species. The evidence for gastrointestinal use remains at the level of traditional practice and historical medical observation.
5.3 Anti-inflammatory and Analgesic Activity
Evidence type: In vitro and animal studies only. No human clinical data.
The pharmacological activity of Cercis species, particularly C. chinensis, is increasingly receiving attention from the academic community. Although modern research has confirmed rich bioactive components, there is currently a lack of systematic chemical and pharmacological reviews. The 2025 review by Sun et al. in Chemistry & Biodiversity summarized anti-inflammatory and analgesic effects of C. chinensis extracts and monomer components. These findings were derived from cellular and animal models and cannot be directly extrapolated to C. occidentalis in humans.
5.4 Hypoglycemic / Alpha-glucosidase Inhibition
Evidence type: In vitro only. No human studies.
Integrating and analyzing existing research data, the pharmacological activities of Cercis extracts and monomer components in antioxidant, hypoglycemic, antibacterial, anti-Alzheimer's disease, and immune regulation were characterized in preclinical studies. Alpha-glucosidase inhibitory activity — relevant to blood glucose management — has been identified in C. chinensis flower extracts in vitro. No human trials have been conducted.
5.5 Antimicrobial Activity
Evidence type: In vitro only.
Bacteriostatic and antibacterial activities have been reported for Cercis genus extracts in laboratory settings. Pharmacological investigations have revealed anti-inflammatory, antioxidant, antithrombotic, bacteriostatic, anticoagulant, and hypoglycemic activities for the genus in preclinical work. The clinical relevance of these findings for C. occidentalis specifically remains undetermined.
5.6 Antitumor Activity
Evidence type: Preliminary, in vitro only.
Antitumor activity has been noted in preclinical studies of Cercis genus extracts. The presence of phenolic compounds in Cercis plants suggests a range of potential biological activities, including antioxidant, anti-inflammatory, and other health-promoting effects. However, C. occidentalis has not been evaluated in antitumor studies, and any antineoplastic claims regarding this specific species lack scientific basis at present.
5.7 Neurological Activity (Acetylcholinesterase Inhibition)
Evidence type: In vitro only.
Research on the related C. glabra found compounds inhibiting acetylcholinesterase in enzymatic assays — a mechanism relevant to Alzheimer's disease research. All isolated compounds were evaluated for inhibitory activities against mushroom tyrosinase and acetylcholinesterase. This work is preliminary and has not been replicated in animal or human studies for any Cercis species.
6. Body Systems and Health Areas Associated with California Redbud
- Gastrointestinal system: The most historically established area of use. The astringent bark and root bark preparations were applied to diarrhea, dysentery, and gastrointestinal irritation across multiple indigenous and eclectic medical traditions.
- Respiratory system: A cold infusion of the roots and inner bark has been used to treat various chest complaints including whooping cough and congestion.
- Immune and febrile conditions: A tea made from the inner bark is highly astringent, and has been used in the treatment of fevers, diarrhea, and dysentery.
- Skin and integument (genus-level): Tyrosinase inhibitory activity identified in C. glabra leaf extracts has been discussed in the context of skin aging and hyperpigmentation research, though no clinical evidence in humans exists.
- Metabolic health (preclinical only): Alpha-glucosidase inhibition in vitro suggests potential relevance to glycemic regulation; no human evidence exists for C. occidentalis.
- Antioxidant / cellular protection (preclinical only): Genus-level in vitro data demonstrate free-radical scavenging relevant to general cellular protection; human relevance is not established.
7. Dosage Forms and Reported Dosages
There are no standardized dosage recommendations for California redbud (C. occidentalis) as a dietary supplement in any pharmacopeia, government health body, or peer-reviewed clinical trial. The following preparations are documented in the historical and ethnobotanical literature only:
- Bark infusion (tea): Inner bark or root bark was prepared as a hot or cold-water infusion by various Native American groups and by eclectic physicians. No specific measured dosage is recorded in peer-reviewed sources.
- Fluid extract: An astringent fluid extract from redbud bark has been used in treating dysentery, but no standardized concentration or dose is cited in available scientific literature.
- Flowers as food: Consumed fresh, raw, cooked, pickled, or in tea — in whatever quantity was encountered in seasonal foraging. No quantified therapeutic dose has been reported.
- Seeds: Consumed roasted or raw. On a zero moisture basis, the seed contains 22.9–27.5% protein, 7.7–8.8% fat, and 3% ash (figures for C. canadensis), but no therapeutic dosage is documented.
The absence of any dosage data from clinical trials means that no evidence-based dosage guidance can be provided for any part of this plant.
8. Safety Considerations
Saponin Content
The plant is reported to contain a toxic saponin. Although toxic, saponins are poorly absorbed by the body and most pass straight through without any problem. They are also broken down to a large extent in the cooking process. Saponins are found in many foods, such as some beans. Saponins are much more toxic to some creatures, such as fish, and hunting tribes have traditionally put large quantities of them in streams and lakes in order to stupefy or kill the fish. The practical significance of saponin content for human consumers at food-use quantities is generally considered low, but the specific saponin type and concentration in C. occidentalis tissues have not been characterized in modern analytical studies.
Tannin Concentration in Bark
The bark has a high concentration of tannins, so it may not be the most pleasant-tasting tea, and large amounts can cause digestive issues. High tannin intake over extended periods has been associated with gastrointestinal irritation in the general botanical literature. The eclectic use of redbud bark as an astringent was predicated on this tannin content, but therapeutic doses were not systematically characterized.
Absence of Alkaloids and Crystalline Glucosides
Redbud (Cercis canadensis) was found to contain neither alkaloid nor crystalline glucoside in early chemical analysis; the only constituent of marked characteristic was the tannin that gave the astringency. This early observation has not been comprehensively updated with modern phytochemical screening for C. occidentalis specifically.
Absence of Formal Toxicity Data
No formal acute or chronic toxicity studies, no reproductive toxicity data, and no drug interaction studies have been published for C. occidentalis in any peer-reviewed source located in standard databases (PubMed, PMC). The plant does not appear in any government pharmacopeia (USP, European Pharmacopoeia, WHO monographs) as a regulated herbal medicinal product, meaning no official safety profile has been established.
Regulatory Status
California redbud is not listed as a regulated dietary supplement ingredient by the U.S. FDA, not monographed by the NIH Office of Dietary Supplements, and is not reviewed by the European Medicines Agency or the European Food Safety Authority. It has no GRAS (Generally Recognized as Safe) designation in the context of supplemental use. Its traditional food use (flowers, young pods, leaves, seeds in small quantities as part of a varied diet) has not triggered safety concerns in the ethnobotanical record, but formal safety evaluation has not been performed.
9. Evidence Gaps and Research Limitations
The scientific literature on California redbud (C. occidentalis) specifically is extremely limited. Compared with other genera of legumes, the previous studies on the chemical constituents and bioactivities of the Cercis plant are very scarce. The following gaps are notable:
- No phytochemical characterization study has been published specifically for C. occidentalis tissue extracts in a peer-reviewed journal.
- No human clinical trials of any kind have been conducted for California redbud or any closely related North American redbud species.
- All pharmacological activity data derive from the Asian relatives C. chinensis and C. glabra, which, while phylogenetically informative, cannot be assumed to be identical in composition or potency to the North American species.
- No standardized extract, defined dose, or validated biomarker study exists for any preparation of this plant.
- Systematic toxicological evaluation is entirely absent from the published record.
References
Go back